Advertisement
YOU ARE HERE: LAT HomeCollectionsVera Price
IN THE NEWS

Vera Price

FEATURED ARTICLES
NEWS
September 28, 1999 | TERENCE MONMANEY, TIMES MEDICAL WRITER
The current New England Journal of Medicine--one of the world's top outlets of clinical information--carries a favorable article on two popular hair-loss treatments without disclosing the author's financial ties to the companies that make the drugs. Publication of the article, by Dr. Vera Price, a UC San Francisco professor of clinical dermatology, raises questions about the journal's monitoring of potential conflicts of interest.
ARTICLES BY DATE
NEWS
September 28, 1999 | TERENCE MONMANEY, TIMES MEDICAL WRITER
The current New England Journal of Medicine--one of the world's top outlets of clinical information--carries a favorable article on two popular hair-loss treatments without disclosing the author's financial ties to the companies that make the drugs. Publication of the article, by Dr. Vera Price, a UC San Francisco professor of clinical dermatology, raises questions about the journal's monitoring of potential conflicts of interest.
Advertisement
MAGAZINE
April 2, 1989 | PADDY CALISTRO
A $17.50 SHAMPOO? La Prairie, an upscale cosmetics line sold at Bullocks Wilshire and Neiman Marcus, now offers a 3.4-ounce tube containing placenta protein and plant extracts that "draw impurities from the hair" rather than cleanse it with detergents, according to Georgette Mosbacher, La Prairie chairman and chief executive officer. At more than $5 per ounce, La Prairie probably won't provide major competition for Procter & Gamble's Head & Shoulders, America's sales leader.
NEWS
December 23, 1997 | MARLENE CIMONS, TIMES STAFF WRITER
The Food and Drug Administration on Monday approved the first-ever pill to fight baldness, providing another rare weapon for man's seemingly endless battle against hair loss. The new pill, called Propecia, is manufactured by Merck & Co. of West Point, Pa., and is expected to cost about $45 a month. It will be available by prescription in mid-January. It helps male pattern baldness only--promoting hair growth mostly on the top of the head and the front mid-scalp areas. "This is real hair," Dr.
HEALTH
August 6, 2001 | DENISE HAMILTON
Hair loss can be traumatic at any age, and not only for men who slowly watch a bald spot spread across their heads. The technical name for hair loss is alopecia, a Latin term that refers to baldness in any form. Alopecia areata is a condition that affects an estimated 2% of the population, or 4 million Americans, including children.
NEWS
February 13, 1996 | SHERYL STOLBERG, TIMES STAFF WRITER
Balding Americans, take note: The federal government has just made it a little easier to wage war on Mother Nature. Eight years after approving the first and only known medical treatment for hereditary baldness, the FDA took that action one step further Monday, making Rogaine an over-the-counter drug as easy to obtain from a pharmacy as aspirin. The move, which reverses an earlier FDA decision, prompted the drug's manufacturer, Michigan-based Pharmacia & Upjohn Inc.
NEWS
February 24, 2000 | TERENCE MONMANEY, TIMES MEDICAL WRITER
The world's most influential medical journal has admitted to an extraordinary betrayal of its own ethics, saying that nearly half of the drug reviews published since 1997 were written by researchers with undisclosed financial support from companies marketing the drugs. The New England Journal of Medicine, in an unusual internal probe published in today's edition, found that 19 out of about 40 drug therapy reviews violated its famously tough conflict-of-interest policy.
NEWS
November 15, 1991 | ROSE-MARIE TURK, TIMES STAFF WRITER
For two years, California businesswoman Rita Lazar panicked every time she looked at her hair. It was thinning and she couldn't stop the process. But Lazar is lucky. Diagnosed with androgenetic alopecia, or genetic hair loss, she was able to stop the fallout and regrow hair with minoxidil, the only FDA-approved treatment for her condition. Patented by Upjohn and marketed as Rogaine, the topical preparation was introduced for men only in 1988.
MAGAZINE
September 21, 1986 | DEBORAH BLUMENTHAL, Deborah Blumenthal is a writer based in New York.
Summer is ending, but concerns about protection from the sun should continue after beach season is a memory, skin-care experts now say. "You accumulate far more damage in 50 weeks going to and from work than in two weeks in Hawaii," says Dr. Vera H. Price, clinical professor of dermatology at the University of California, San Francisco.
NEWS
October 21, 1999 | TERENCE MONMANEY, TIMES MEDICAL WRITER
The renowned New England Journal of Medicine--the world's top-ranked medical journal and a leading voice in biomedical ethics--has apparently violated its own ethics policy numerous times in the last three years, publishing articles by researchers with drug company ties and not disclosing the potential conflicts of interest.
Los Angeles Times Articles
|